Français📈 See the interactive version (live chart) →
For Repligen, we replayed every analyst price target of the past 12 months and measured the real outcome: 35% were profitable, average return +16% (82 calls). At 3 months: +5% average return (50% profitable). The higher the %, the more often analysts were right on this stock.
Their past track record on this stock (targets replayed against real prices) — not a forecast of what will happen.
| Analyst / broker | Calls i | % profitable i | Avg return i |
|---|---|---|---|
| HC Wainwright & Co. | 12 | 50% | +27% |
| RBC Capital | 10 | 10% | -10% |
| JP Morgan | 8 | 25% | +0% |
| Stifel | 7 | 57% | +55% |
| SVB Leerink | 7 | 14% | -1% |
The analyst consensus on Repligen (RGEN) is "Buy" (21 bullish, 0 bearish calls over 12 months). This is not advice: historically, 35% of their targets on this stock turned out profitable over 1 year.
The median 12-month price target is $185 (-2% vs $189), ranging from $150 to $225 (9 analysts).
Over 1 year, 35% of analyst targets on Repligen were profitable, for an average return of +16% (across 82 timestamped calls). This is JPI Invest's accuracy metric.
Analysts target a median of $185 within 12 months, i.e. -2% vs the current price. The most bullish targets $225, the most cautious $150.
Note: analyst targets are 12-month (median $185, -2%), NOT 2030. No reliable 5-10 year price forecast exists (« 2030 prediction » models are speculative). The most useful inputs: the 12-month median above, these analysts' historical accuracy (35%), and the stock's past trajectory.
Detailed valuation data for Repligen is available in the interactive analysis.
📊 See the full interactive analysis of Repligen →
JPI Invest aggregates analyst recommendations across the entire S&P 500 (plus the S&P MidCap 400), replays them against real prices and measures who predicts best — on results, not reputation. Instead of taking a price target at face value, you see each analyst's track record on each stock.
⚠️ Educational information, not investment advice. Analyst price targets are 12-month and can be wrong. Data via Yahoo Finance, recomputed by JPI Invest.